Is Defibrotide/Defibrotide on the market in China?

Defibrotide/Defibrotide (Defibrotide) is a drug used to treat certain blood disorders. It is a biologic agent used primarily to treat hepatic veno-occlusive disease (such as hepatic veno-occlusive disease and venous liver disease), as well as some other platelet abnormalities and blood clot-related conditions.

The exact mechanism of this drug is not fully understood, but it is believed that it may affect vascular endothelial cells and the coagulation system through multiple pathways, thereby improving blood flow and reducing thrombosis. Defibrotide/Defibrotide Sodium is considered to have anti-platelet aggregation, anticoagulation and fibrinolytic activation effects, helping to maintain the normal flow of blood within blood vessels.

Defibrotide/Defibrotide is a drug primarily used to treat a specific type of blood disorder called "Venous thrombophlebitis syndrome"(veno-occlusive disease, VOD). VOD Usually occurs in patients who have undergone hematopoietic stem cell transplantation (such as bone marrow transplantation), and may also occur in some chemotherapy regimens. Please note that information about medicines may be updated over time, so it is best to consult a medical professional or refer to the most recent drug package insert when using or learning about a specific medicine.

Defibrinoside/Defibrotide SodiumIt is not currently on the market in China, let alone covered by medical insurance, so patients cannot purchase it domestically and need to purchase it through foreign purchasing channelsDefibrotide Sodium/Defibrotide Sodium. OverseasDefibrinoside/Defibrotide Sodium only has original drugs and no generic drugs. The cheaper original drugs are Turkish original drugs, which cost about 21,000 yuan, which is still very high.